Liquid Based Cervical Cytology : How to Diagnose LBC smears | Surepath vs ThinPrep
SLIDESHARE PATHOLOGY
0:00 / 0:00
Liquid Based Cervical Cytology : How to Diagnose LBC smears | Surepath vs ThinPrep
860 просмотров · 2 г. назад
SLIDESHARE PATHOLOGY
3,52 тыс. подписчиков
860 просмотров · 2 г. назад
Liquid Based Cervical Cytology : How to Diagnose LBC smears | Surepath vs ThinPrep
Liquid-based cytology is a method of preparing samples for examination in cytopathology. The sample is collected, normally by a small brush, in the same way as for a conventional smear test, but rather than the smear being transferred directly to a microscope slide, the sample is deposited into a small bottle of preservative liquid. At the laboratory, the liquid is treated to remove other elements such as mucus before a layer of cells is placed on a slide.
Methods
SurePath: In the SurePath method, the sample is vortexed, strained, layered onto a density gradient, and centrifuged. Instruments required are a computer-controlled robotic pipette and a centrifuge. The cells form a circle 12.5 mm in diameter.
Thinprep: The ThinPrep method requires an instrument and special polycarbonate filters. After the instrument immerses the filter into the vial, the filter is rotated to homogenize the sample. Cells are collected on the surface of the filter when a vacuum is applied. The filter is then pressed against a slide to transfer the cells into a 20 mm diameter circle.
Comparison to conventional smear
Liquid-based cytology improves specimen adequacy.
The most significant alterations seen with the ThinPrep technique include:
Selective loss of extracellular material, which prevents it from obscuring cells, but may cause a loss of diagnostic clues.
Selective loss of small cells
Fragmentation of large sheets and papillae
Absence of smearing artifacts seen on conventional smears, which usually facilitates the diagnosis, but also removes the opportunity to see characteristic smearing artifacts such as chromatin smearing in small-cell carcinoma.
As studied on SurePath and ThinPrep, early trials showed increased detection of high-grade cervical intraepithelial neoplasia (CIN2 and CIN3), but subsequent meta-analyses and prospective randomized trials have failed to demonstrate a significant difference between conventional smears and liquid cytology in the detection of CIN2 and CIN3.